Literature DB >> 15908622

Immunogenicity of routine vaccination against diphtheria, tetanus, and Haemophilus influenzae type b in Asian infants born in the United Kingdom.

R Booy1, E A Haworth, K A Ali, H M Chapel, E R Moxon.   

Abstract

AIM: To determine the immunogenicity of routine vaccination against diphtheria, tetanus, and Haemophilus influenzae type b (Hib) in Asian infants born in the UK, and whether maternal antibody suppression occurs.
METHODS: A cohort study with 80% power, within 95% confidence limits, to show that 80% or fewer Asian infants would respond with an anti-PRP antibody concentration >0.15 microg/ml. Infants of South Asian origin born in Berkshire were enrolled at two general practices in Reading: 41 Asian families sequentially asked to participate within 2 weeks of birth; 36 infants were enrolled and 34 completed the study. Main outcome measures were: antibody concentration against diphtheria, tetanus, and Hib expressed as geometric mean titres (GMT) and proportion of infants about a threshold protective antibody concentration.
RESULTS: Median age for completing primary vaccination course was 5 months. All 34 achieved anti-PRP antibody concentration of >0.15 microg/ml, 33 were >1.0 microg/ml, and the GMT was 15.0 microg/ml. All infants developed protective antibody concentration >0.1 IU/ml for tetanus and diphtheria; the respective GMTs were 1.94 and 5.57 IU/ml. Infants with high (>0.25 IU/ml) antibody concentrations against diphtheria and tetanus at 2 months achieved lower antibody concentrations after their three dose course than those with low concentrations (<0.1 IU/ml) (p = 0.06 and 0.03, respectively).
CONCLUSIONS: Despite evidence for maternal antibody suppression of the response to tetanus and diphtheria vaccination, excellent antibody responses were achieved by routine vaccination according to the accelerated schedule. High vaccine coverage should be encouraged to provide protection against the possibility of imported infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908622      PMCID: PMC1720432          DOI: 10.1136/adc.2004.064469

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

Review 1.  World-wide epidemiology of Haemophilus influenzae meningitis; industrialized versus non-industrialized countries.

Authors:  H A Bijlmer
Journal:  Vaccine       Date:  1991-06       Impact factor: 3.641

2.  No sex differences in immunisation rates of British south Asian children: the effect of migration?

Authors:  A Martineau; M White; R Bhopal
Journal:  BMJ       Date:  1997-03-01

3.  Diphtheria--the continuing hazard.

Authors:  I C Bowler; B K Mandal; B Schlecht; T Riordan
Journal:  Arch Dis Child       Date:  1988-02       Impact factor: 3.791

4.  Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.

Authors:  R Booy; S A Taylor; S R Dobson; D Isaacs; G Sleight; S Aitken; H Griffiths; H Chapel; R T Mayon-White; J A Macfarlane
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

5.  Uptake of immunisation in district health authorities in England.

Authors:  B Jarman; N Bosanquet; P Rice; N Dollimore; B Leese
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-25

6.  Immunization uptake of Glasgow Asian children: paradoxical benefit of communication barriers?

Authors:  R S Bhopal; A K Samim
Journal:  Community Med       Date:  1988-08

7.  Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age.

Authors:  R Booy; S J Aitken; S Taylor; G Tudor-Williams; J A Macfarlane; E R Moxon; L A Ashworth; R T Mayon-White; H Griffiths; H M Chapel
Journal:  Lancet       Date:  1992-02-29       Impact factor: 79.321

8.  Prospective study of bacterial meningitis in North East Thames region, 1991-3, during introduction of Haemophilus influenzae vaccine.

Authors:  G Urwin; M F Yuan; R A Feldman
Journal:  BMJ       Date:  1994-11-26

9.  Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.

Authors:  R Booy; S Hodgson; L Carpenter; R T Mayon-White; M P Slack; J A Macfarlane; E A Haworth; M Kiddle; S Shribman; J S Roberts
Journal:  Lancet       Date:  1994-08-06       Impact factor: 79.321

10.  Risk factors for invasive Haemophilus influenzae type b in Los Angeles County children 18-60 months of age.

Authors:  C M Vadheim; D P Greenberg; N Bordenave; L Ziontz; P Christenson; S H Waterman; J I Ward
Journal:  Am J Epidemiol       Date:  1992-07-15       Impact factor: 4.897

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.